Mgc Pharmaceuticals Ltd. (MGCLF) has released an update.
Argent BioPharma Ltd. has commenced trading on the OTCQB Venture Market in the U.S., under the ticker MGCLF, with aims to enhance liquidity and investor access by trading in U.S. dollars during U.S. market hours. The company has also appointed a new CFO, Igor Bluvstein, bringing over 15 years of experience in finance across diverse industries. This move is expected to diversify Argent BioPharma’s investor base and augment its progress in drug development.
For further insights into MGCLF stock, check out TipRanks’ Stock Analysis page.
